This World AIDS Day, Join the Movement to #makeHIVhistory
Together with partners around the world, Johnson & Johnson has been working to fight HIV for 25 years. Despite significant progress, UNAIDS estimates that there are still 36.7 million people living with HIV globally and 1.8 million people continue to contract the disease each year. Johnson & Johnson continues to work towards our goals of ensuring that every child is born HIV-free, that adolescent girls and young women have the tools they need to stay HIV-free, and that people living with HIV have access to the medicines they need.
This World AIDS Day, December 1, 2017, join the movement and help us #makeHIVhistory. It takes just 15 seconds to support people living with HIV by creating your own video at MakeHIVHistory.com or uploading a photo using the Donate a Photo app:
- Get Involved and Upload a Video
Record a video at MakeHIVHistory.com. Simply visit the website, tap to record your video, and share to help end HIV. Johnson & Johnson will be unveiling the winning video submissions on World AIDS Day.
- Take Action and Donate a Photo
For every photo shared through the Donate a Photo app, Johnson & Johnson gives $1 to a cause you care about. Select the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) or the Black AIDS Institute causes to help people living with HIV. 117 people living with HIV have been supported from the donation of 2,936 photos to date – together, we can help more people living with this disease. Upload your photo now.
At Johnson & Johnson, we will not rest until we defeat HIV. To learn more about our commitment to tackling some of the world’s biggest health challenges, including infectious diseases like HIV, visit jnj.com/progressand learn more about progress on our HIV vaccine and work to improve the health of people around the world. Also, learn more about our work to support people living with this disease in this article on GlobalCitizen.org featuring Donna Sabatino, RN, ACRN, HIV/AIDS nurse educator and senior community liaison, Janssen Infectious Diseases, Johnson & Johnson.